equityflowunderstand the flow and follow it
EquityFlow › Companies › CV6 Therapeutics

CV6 Therapeutics

Biotech · Belfast, GB · cv6therapeutics.com

Belfast biotech developing the anti-cancer drug CV6-168.

In the network

Shares the most investors with (number = shared investors):
AntennaWare 2Axial3D 2Neurovalens 2Re-Vana Therapeutics 2

Funding history

DateRoundAmount
Nov 2022Funding round
Belfast biotech CV6 Therapeutics raised £8m (incl. a £3m Invest NI grant) from QUBIS, Techstart and Clarendon to trial its cancer drug.
$9.6M

Investors

Tap an investor to see what else they have backed.

Clarendon Fund ManagersInvest NIQUBISTechstart Ventures

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in GB

Capsa AI01HealthRem3dy HealthNewOrbitJoyvié HealthFuse EnergyAirspeedSembleWordsmithOxford Quantum CircuitsFreshaImperagen
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.